Beyond Genes: Inclusion of Alternative Splicing and Alternative Polyadenylation to Assess the Genetic Architecture of Predisposition to Voluntary Alcohol Consumption in Brain of the HXB/BXH Recombinant Inbred Rat Panel.

HXB/BXH recombinant inbred panel RNA-seq—RNA sequencing alternative polyadenylation alternative splicing isoform transcriptome voluntary alcohol consumption weighted gene co expression network analysis

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2022
Historique:
received: 23 11 2021
accepted: 10 02 2022
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 5 4 2022
Statut: epublish

Résumé

Post transcriptional modifications of RNA are powerful mechanisms by which eukaryotes expand their genetic diversity. For instance, researchers estimate that most transcripts in humans undergo alternative splicing and alternative polyadenylation. These splicing events produce distinct RNA molecules, which in turn yield distinct protein isoforms and/or influence RNA stability, translation, nuclear export, and RNA/protein cellular localization. Due to their pervasiveness and impact, we hypothesized that alternative splicing and alternative polyadenylation in brain can contribute to a predisposition for voluntary alcohol consumption. Using the HXB/BXH recombinant inbred rat panel (a subset of the Hybrid Rat Diversity Panel), we generated over one terabyte of brain RNA sequencing data (total RNA) and identified novel splice variants (

Identifiants

pubmed: 35368676
doi: 10.3389/fgene.2022.821026
pii: 821026
pmc: PMC8965255
doi:

Types de publication

Journal Article

Langues

eng

Pagination

821026

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA044223
Pays : United States
Organisme : NIAAA NIH HHS
ID : R24 AA013162
Pays : United States

Informations de copyright

Copyright © 2022 Lusk, Hoffman, Mahaffey, Rosean, Smith, Silhavy, Pravenec, Tabakoff and Saba.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Environ Res Public Health. 2010 Apr;7(4):1448-66
pubmed: 20617039
Immunol Rev. 2013 May;253(1):216-36
pubmed: 23550649
Bioessays. 2014 Aug;36(8):766-77
pubmed: 24903459
BMB Rep. 2019 Feb;52(2):133-138
pubmed: 30078389
Genome Biol. 2017 Nov 30;18(1):229
pubmed: 29191225
BMC Genomics. 2015 May 06;16:357
pubmed: 25943489
Biomark Res. 2020 Nov 25;8(1):67
pubmed: 33292571
Free Radic Biol Med. 2013 Mar;56:89-101
pubmed: 23195683
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11624-9
pubmed: 23798440
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Sci Rep. 2020 Sep 24;10(1):15629
pubmed: 32973177
Nat Genet. 2008 Dec;40(12):1413-5
pubmed: 18978789
Pharmacol Biochem Behav. 2011 Jun;98(4):533-8
pubmed: 21402096
Nat Methods. 2013 Feb;10(2):133-9
pubmed: 23241633
BMC Bioinformatics. 2011 Dec 17;12:480
pubmed: 22177264
Mediators Inflamm. 2018 Aug 9;2018:3067126
pubmed: 30158832
Am J Clin Nutr. 2011 Apr;93(4):809-16
pubmed: 21270382
Nucleic Acids Res. 2020 Sep 4;48(15):8320-8331
pubmed: 32749457
Mol Cells. 2016 Apr 30;39(4):281-5
pubmed: 26912084
Gene. 2013 Feb 1;514(1):1-30
pubmed: 22909801
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Pharmacogenomics J. 2007 Aug;7(4):222-56
pubmed: 17033615
BMC Bioinformatics. 2010 Feb 18;11:94
pubmed: 20167110
Genetics. 2001 Sep;159(1):371-87
pubmed: 11560912
Pharmacogenet Genomics. 2009 Nov;19(11):893-902
pubmed: 19823103
Wiley Interdiscip Rev RNA. 2019 Jul;10(4):e1526
pubmed: 30816016
Nat Rev Mol Cell Biol. 2017 Feb;18(2):102-114
pubmed: 27847391
Nat Rev Mol Cell Biol. 2017 Jan;18(1):18-30
pubmed: 27677860
Nat Biotechnol. 2004 May;22(5):535-46
pubmed: 15122293
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Pharmacol. 2019 Nov;96(5):655-663
pubmed: 31575620
Nat Rev Neurosci. 2001 Jan;2(1):43-50
pubmed: 11253358
Sci Rep. 2014 Dec 12;4:7405
pubmed: 25502009
Genome Res. 2001 Sep;11(9):1520-6
pubmed: 11544195
Methods Mol Biol. 2019;2018:213-231
pubmed: 31228159
Brain Res Mol Brain Res. 1999 Oct 1;72(2):166-75
pubmed: 10529475
Cell. 2012 Jun 22;149(7):1622-34
pubmed: 22726445
J Pharmacol Exp Ther. 2008 Oct;327(1):196-205
pubmed: 18583548
Bioessays. 2000 Jul;22(7):637-45
pubmed: 10878576
Genetics. 2020 May;215(1):103-116
pubmed: 32132098
J Neuroimmune Pharmacol. 2014 Dec;9(5):668-78
pubmed: 25135400
Genome Biol. 2005;6(12):R100
pubmed: 16356263
Pharmacogenomics J. 2004;4(3):208-18
pubmed: 15052257
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
Genetics. 1994 Nov;138(3):963-71
pubmed: 7851788
RNA. 2012 May;18(5):1029-40
pubmed: 22454538
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
J Neuroinflammation. 2019 Jul 20;16(1):152
pubmed: 31325960
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7737-41
pubmed: 9636220
Hum Genomics. 2011 May;5(4):283-303
pubmed: 21712190
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
Neurosci Lett. 2000 Dec 8;295(3):77-80
pubmed: 11090978
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Science. 2013 Aug 30;341(6149):1009-12
pubmed: 23990561
Curr Pharm Des. 2007;13(23):2368-84
pubmed: 17692007
Addict Biol. 2005 Mar;10(1):71-9
pubmed: 15849021
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Genome Res. 2008 Sep;18(9):1509-17
pubmed: 18550803
Nature. 2010 Jan 28;463(7280):457-63
pubmed: 20110989
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15945-50
pubmed: 20733072
BMC Biol. 2009 Oct 27;7:70
pubmed: 19874574
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Commun. 2012;3:1084
pubmed: 23011138
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Annu Rev Genet. 1985;19:253-72
pubmed: 3909943
Nat Genet. 2008 May;40(5):560-6
pubmed: 18443594
Nat Rev Genet. 2003 Nov;4(11):911-6
pubmed: 14634638
Alcohol Clin Exp Res. 2002 Jun;26(6):773-8
pubmed: 12068244
Nat Genet. 1995 Nov;11(3):241-7
pubmed: 7581446
Psychol Med. 2015 Apr;45(5):1061-72
pubmed: 25171596
Physiol Genomics. 2018 Jan 1;50(1):52-66
pubmed: 29127223
Nat Rev Genet. 2007 Oct;8(10):749-61
pubmed: 17726481
Science. 1998 Dec 4;282(5395):1914-7
pubmed: 9836646
Genome Res. 2002 Apr;12(4):656-64
pubmed: 11932250
Alcohol. 2007 Mar;41(2):95-132
pubmed: 17517326
Biol Psychiatry. 2009 Oct 15;66(8):795-800
pubmed: 19576574
Alcohol. 2017 Aug;62:1-9
pubmed: 28755746
Genes Dev. 2003 Feb 15;17(4):419-37
pubmed: 12600935
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Trends Genet. 2002 Mar;18(3):123-7
pubmed: 11858835
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Genes Brain Behav. 2014 Nov;13(8):743-57
pubmed: 25160899
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Neurosci Lett. 2007 Jun 27;421(2):158-62
pubmed: 17566648
Nature. 2004 Apr 1;428(6982):493-521
pubmed: 15057822
Nature. 1998 Jun 18;393(6686):702-5
pubmed: 9641683
Mamm Genome. 2016 Oct;27(9-10):469-84
pubmed: 27401171
Transl Psychiatry. 2021 Jan 5;11(1):2
pubmed: 33414398
Alcohol Clin Exp Res. 2018 Jul;42(7):1177-1191
pubmed: 29689131
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Hypertens. 1989 Mar;7(3):217-21
pubmed: 2708818
J Stud Alcohol Drugs. 2011 May;72(3):453-8
pubmed: 21513682
Alcohol Clin Exp Res. 2014 Jul;38(7):2148-57
pubmed: 24961585
Genome Res. 2004 Apr;14(4):721-32
pubmed: 15060016
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Genome Res. 2012 Jun;22(6):1173-83
pubmed: 22454233
PLoS Genet. 2012;8(8):e1002882
pubmed: 22916029
Genes Brain Behav. 2021 Feb;20(2):e12698
pubmed: 32893479
Mol Cell. 2011 Sep 16;43(6):853-66
pubmed: 21925375
EMBO J. 1998 Jun 15;17(12):3372-84
pubmed: 9628874
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5493-8
pubmed: 22431634
Nat Commun. 2021 Mar 12;12(1):1652
pubmed: 33712618
FEBS J. 2015 Sep;282(18):3556-78
pubmed: 26183165
J Pharmacol Exp Ther. 2010 Sep 1;334(3):720-8
pubmed: 20543096

Auteurs

Ryan Lusk (R)

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Paula L Hoffman (PL)

Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Spencer Mahaffey (S)

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Samuel Rosean (S)

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Harry Smith (H)

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Jan Silhavy (J)

Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia.

Michal Pravenec (M)

Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia.

Boris Tabakoff (B)

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Laura M Saba (LM)

Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Classifications MeSH